CSIMarket
 
Globus Medical Inc   (NYSE: GMED)
Other Ticker:  
 
 
Price: $55.9700 $-3.20 -5.408%
Day's High: $58.875 Week Perf: -5.17 %
Day's Low: $ 55.84 30 Day Perf: -5.07 %
Volume (M): 2,213 52 Wk High: $ 94.93
Volume (M$): $ 123,834 52 Wk Avg: $74.15
Open: $58.75 52 Wk Low: $54.48



 Market Capitalization (Millions $) 7,823
 Shares Outstanding (Millions) 140
 Employees 5,000
 Revenues (TTM) (Millions $) 2,511
 Net Income (TTM) (Millions $) 186
 Cash Flow (TTM) (Millions $) 107
 Capital Exp. (TTM) (Millions $) 128

Globus Medical Inc
Globus Medical Inc. is a medical device company that develops, manufactures, and markets musculoskeletal implants and surgical products. The company's products are designed for patients suffering from conditions such as spinal disorders, trauma, and joint instability. Globus Medical's product portfolio includes devices for spinal fusion, motion preservation, vertebral compression fracture treatment, and orthopedic trauma.

The company was founded in 2003 by David Paul, a former lawyer who had also worked in the medical device industry. He partnered with his brother, a surgeon, and together they set out to create a company that would revolutionize the field of musculoskeletal care. Since then, the company has grown rapidly, becoming one of the most successful medical device companies in the world.

Globus Medical operates in over 25 countries worldwide, with a strong presence in the United States, Europe, and Asia. The company's headquarters is located in Audubon, Pennsylvania, where it employs approximately 2,500 people. The company also has several manufacturing facilities located in the United States and Europe.

Globus Medical's product portfolio includes more than 160 products across four categories: spine, trauma, Orthobiologics, and joint replacement. The company's spine products comprise of implants and devices that treat conditions such as spinal stenosis, herniated discs, and scoliosis. The company's trauma products include systems that provide treatment for fractures and other injuries. The company's Orthobiologics segment covers various solutions for bone and soft tissue healing. The joint replacement segment provides implants for various joints, including the hip, knee, shoulder, and elbow.

Globus Medical's dedication to research and development has been one of the driving forces behind its success. The company invests heavily in developing innovative products and technologies that improve patient outcomes and reduce healthcare costs. The company has a team of more than 300 engineers and researchers who work to create new products and improve existing ones. Moreover, the company has over 470 patents to its name, reflecting the organization's focus on innovation.

Since going public in 2012, Globus Medical has experienced tremendous growth. The company's revenue has increased from $419 million in 2012 to a whooping $857 million in 2019. The company's commitment to delivering high-quality products and services has earned it numerous industry accolades, including being named one of the fastest-growing companies in the United States in recent times.

In conclusion, Globus Medical Inc is a leading medical device company that has revolutionized the field of musculoskeletal care. The company's strong focus on research and development, combined with its commitment to improving patient outcomes have made it one of the most successful and recognized players in the medical device industry. With its portfolio of innovative products, extensive global reach, and dedicated workforce, the company is poised to continue its growth and dominance in the coming years.


   Company Address: 2560 General Armistead Avenue Audubon 19403 PA
   Company Phone Number: 930-1800   Stock Exchange / Ticker: NYSE GMED


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CNMD        4.14% 
ENOV        5.88% 
EW   -1.82%    
SYK        0.44% 
TFX        0.36% 
ZBH        2.42% 
• View Complete Report
   



Announcement

Globus Medical Reports Steady Q1 2025 Results Amid Competitive Landscape,

Published Sun, May 11 2025 7:34 PM UTC

Globus Medical Reports First Quarter 2025 Results AUDUBON, Pa. May 08, 2025 Globus Medical, Inc. (NYSE: GMED), a prominent player in the musculoskeletal solutions sector, has announced its financial results for the first quarter of 2025. The company demonstrated resilience amid challenging market conditions as it revealed its performance metrics, including a notable decre...

Merger and Acquisition

Globus Medical Concludes $250 Million Acquisition of Nevro Corp: A Strategic Move to Revolutionize Pain Management

Published Thu, Apr 3 2025 12:31 PM UTC

Globus Medical Marks a New Era in Pain Management with Acquisition of Nevro CorpAUDUBON, Pa. April 3, 2025 ? In a landmark move that underscores its commitment to enhancing patient outcomes and expanding its product offerings, Globus Medical, Inc. (NYSE: GMED), a prominent player in the musculoskeletal technology arena, has successfully completed its acquisition of Nevro Cor...

Merger and Acquisition

Breaking : Globus Medical to Acquire Nevro Corp in $250 Million All-Cash Deal

Published Thu, Feb 6 2025 2:31 PM UTC

Breaking News: Globus Medical to Acquire Nevro Corp. in $250 Million All-Cash DealAUDUBON, Pa. and REDWOOD CITY, Calif. February 6, 2025 ? In a significant move within the medical device industry, Globus Medical (NYSE: GMED), a prominent player in musculoskeletal solutions, has announced a definitive agreement to acquire Nevro Corp. (NYSE: NVRO), a global leader in chronic p...

Product Service News

Globus Medical Pioneers the Future of Orthopedic Care with Cutting-Edge Trauma Solutions and Robotic Syst...

Published Wed, Oct 2 2024 8:15 PM UTC

In a significant stride forward in the field of musculoskeletal health, Globus Medical, Inc. (NYSE: GMED), a leading innovator in orthopedic solutions, has announced the expansion of its already comprehensive orthopedic trauma product lineup. The latest announcement, dated October 2, 2024, signals a pivotal growth phase for the company as it reaffirms its commitment to provi...

Product Service News

A New Epoch in Medical Innovation Globus Medical Inc. Unveils the ADIRA XLIF Plate System Amidst Financial Variances,...

Published Wed, Aug 21 2024 8:15 PM UTC

Globus Medical Heralds New Dawn with ADIRA XLIF Plate SystemIn an age where the boundaries of scientific and medical ingenuity seem ever-expansive, it is with great anticipation and fanfare that we herald the advent of Globus Medical Inc. s latest innovation the ADIRA XLIF Plate System. The esteemed establishment, a paragon in the realm of musculoskeletal solutions, announc...







Globus Medical Inc's Segments
United States    80.9 % of total Revenue
International    19.1 % of total Revenue

  Globus Medical Inc Outlook

On January 10 2024 the Globus Medical Inc provided following guidance

Globus Medical, Inc., a renowned company in musculoskel...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com